中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2014年
2期
104-108
,共5页
仝春冉%张中和%马春梅%朱颖%张秀伟
仝春冉%張中和%馬春梅%硃穎%張秀偉
동춘염%장중화%마춘매%주영%장수위
肺栓塞%预后%简化肺栓塞严重性指数%B型尿钠肽%超敏肌钙蛋白Ⅰ
肺栓塞%預後%簡化肺栓塞嚴重性指數%B型尿鈉肽%超敏肌鈣蛋白Ⅰ
폐전새%예후%간화폐전새엄중성지수%B형뇨납태%초민기개단백Ⅰ
Pulmonary embolism%Prognosis%Simplified pulmonary embolism severity index%Brain natriuretic peptide%High-sensitivity troponin Ⅰ
目的 分析简化肺栓塞严重性指数(sPESI)及B型尿钠肽(BNP)、超敏肌钙蛋白Ⅰ(hs-TnⅠ)在肺栓塞短期及长期预后评价中的作用及联合检测的意义.方法 收集大连医科大学附属第一医院2010年1月至2012年9月连续162例肺栓塞患者资料,其中男68例,女94例,以院内死亡、休克、机械通气、心肺复苏为主要终点,以38个月内的死亡为次要终点,在全部人群及血流动力学稳定亚组中分析sPESI、BNP、hs-TnI等与主要及次要终点的联系,进行变量回归分析,筛选最佳指标,评价联合检测的价值.结果 162例患者主要终点多变量回归中,只有BNP、hs-TnⅠ、sPESI为独立预测因素,ROC曲线面积、OR值分别为0.87、8.16,0.91、6.09和0.78、14.07.血流稳定亚组的主要终点多变量回归中,仅BNP、sPESI是独立预测因素.次要终点的COX分析中,仅sPESI是独立危险因素.联合BNP、hs-TnⅠ后院内事件的阳性预测值提高(44.4%),阴性预测值未下降(97.8%),均阴性或单阳性患者中,没有主要终点发生于sPESI低危组.结论 sPESI能够反映肺栓塞的整体风险,在肺栓塞预后尤其是长期预后评价中有较高价值,可以被融合进肺栓塞的风险评价中.在肺栓塞短期预后评价中,BNP、hs-TnⅠ是最优秀指标.三者联合可以更全面地评估肺栓塞的短期及长期预后.
目的 分析簡化肺栓塞嚴重性指數(sPESI)及B型尿鈉肽(BNP)、超敏肌鈣蛋白Ⅰ(hs-TnⅠ)在肺栓塞短期及長期預後評價中的作用及聯閤檢測的意義.方法 收集大連醫科大學附屬第一醫院2010年1月至2012年9月連續162例肺栓塞患者資料,其中男68例,女94例,以院內死亡、休剋、機械通氣、心肺複囌為主要終點,以38箇月內的死亡為次要終點,在全部人群及血流動力學穩定亞組中分析sPESI、BNP、hs-TnI等與主要及次要終點的聯繫,進行變量迴歸分析,篩選最佳指標,評價聯閤檢測的價值.結果 162例患者主要終點多變量迴歸中,隻有BNP、hs-TnⅠ、sPESI為獨立預測因素,ROC麯線麵積、OR值分彆為0.87、8.16,0.91、6.09和0.78、14.07.血流穩定亞組的主要終點多變量迴歸中,僅BNP、sPESI是獨立預測因素.次要終點的COX分析中,僅sPESI是獨立危險因素.聯閤BNP、hs-TnⅠ後院內事件的暘性預測值提高(44.4%),陰性預測值未下降(97.8%),均陰性或單暘性患者中,沒有主要終點髮生于sPESI低危組.結論 sPESI能夠反映肺栓塞的整體風險,在肺栓塞預後尤其是長期預後評價中有較高價值,可以被融閤進肺栓塞的風險評價中.在肺栓塞短期預後評價中,BNP、hs-TnⅠ是最優秀指標.三者聯閤可以更全麵地評估肺栓塞的短期及長期預後.
목적 분석간화폐전새엄중성지수(sPESI)급B형뇨납태(BNP)、초민기개단백Ⅰ(hs-TnⅠ)재폐전새단기급장기예후평개중적작용급연합검측적의의.방법 수집대련의과대학부속제일의원2010년1월지2012년9월련속162례폐전새환자자료,기중남68례,녀94례,이원내사망、휴극、궤계통기、심폐복소위주요종점,이38개월내적사망위차요종점,재전부인군급혈류동역학은정아조중분석sPESI、BNP、hs-TnI등여주요급차요종점적련계,진행변량회귀분석,사선최가지표,평개연합검측적개치.결과 162례환자주요종점다변량회귀중,지유BNP、hs-TnⅠ、sPESI위독립예측인소,ROC곡선면적、OR치분별위0.87、8.16,0.91、6.09화0.78、14.07.혈류은정아조적주요종점다변량회귀중,부BNP、sPESI시독립예측인소.차요종점적COX분석중,부sPESI시독립위험인소.연합BNP、hs-TnⅠ후원내사건적양성예측치제고(44.4%),음성예측치미하강(97.8%),균음성혹단양성환자중,몰유주요종점발생우sPESI저위조.결론 sPESI능구반영폐전새적정체풍험,재폐전새예후우기시장기예후평개중유교고개치,가이피융합진폐전새적풍험평개중.재폐전새단기예후평개중,BNP、hs-TnⅠ시최우수지표.삼자연합가이경전면지평고폐전새적단기급장기예후.
Objective To evaluate the value of simplified pulmonary embolism severity index (sPESI),brain natriuretic peptide (BNP) and high-sensitivity troponin Ⅰ (hs-TnⅠ) in predicting the short-term and long-term prognosis of patients with acute pulmonary embolism.Methods We collected the clinical data of 162 consecutive patients with acute pulmonary embolism in The First Affiliated Hospital of Dalian Medical University from January of 2010 to September of 2012.Hospital death,shock,mechanical ventilation and cardiopulmonary resuscitation were defined as the primary endpoints while death within 38 months as the secondary endpoint.The correlations between sPESI,BNP and hs-TnⅠ,and the primary and secondary endpoints in the overall cohort and hemodynamically stable subgroup were analyzed respectively.Results BNP,hs-TnⅠ and sPESI were independent predictors in multivariate regression of the primary endpoints in the overall cohort.The area under ROC curve and the risk odds ratio of them were 0.87,8.16 ;0.91,6.09 and 0.78,14.07 respectively.Only BNP and sPESI were independent predictors in multivariate regression of the primary endpoints in hemodynamically stable subgroup.Only sPESI was an independent risk factor in COX regression of the secondary endpoint.The combination of BNP and hs-TnⅠ further improved the positive predictive value (44.4%),while the negative predictive value was unaffected (97.8%).There was no adverse event in patients with low score of sPESI and single-positive or negative combination of BNP and hs-TnⅠ.Conclusion sPESI could reflect overall risk of pulmonary embolism.It had a high value in the evaluation of pulmonary embolism prognosis,especially for long-term prognosis.It should be integrated into the risk stratification strategy of pulmonary embolism.In the evaluation of short-term prognosis,BNP and hs-TnⅠ were the best indicators,and the combination of BNP,hs-TnⅠ and sPESI could further improve the prognostic value.